NEW YORK (GenomeWeb News) – New England Biolabs today announced a manufacturing and supply agreement with molecular diagnostics firm Lumora.

NEB will manufacture and supply its Bst 2.0 DNA polymerase, a component of Lumora's Bioluminescent Assay in Real Time technology. The product is an in silico-designed homologue of Bacillus stearothermophilus DNA polymerase I, large fragment, NEB said on its website, and is used for isothermal amplification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.